Skip to content

Kyukyu Pharmaceutical Co., Ltd.

Japanese pharmaceutical company specializing in transdermal patches and film formulations.

Last updated September 16, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Kyukyu Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company established in October 1963. It describes itself as a specialist manufacturer of transdermal absorption formulations, having developed technologies in anti-inflammatory analgesic patches, systemically acting tapes, and oral film formulations. The company is headquartered in Nihonbashi Honcho, Chuo, Tokyo, with its business headquarters and Toyama plant in Imizu, Toyama. It develops, manufactures, and sells prescription and over-the-counter pharmaceuticals.

History

Kyukyu Pharmaceutical Co., Ltd. was established in October 1963 as a pharmaceutical sales company. It obtained a pharmaceutical manufacturing license in 1969. The Toyama plant was completed in 1994 with a plaster manufacturing line, expanded in 1996 with a poultice manufacturing line, and expanded again in 2005 with film and tape manufacturing lines. In 2002, Yasuhiko Inada became Representative Director and President. In 2011, the Toyama plant was expanded with a quality control building and an additional film manufacturing line. The company states that it has specialized in external anti-inflammatory analgesic poultices and topical analgesic/anti-inflammatory tapes for the orthopedic field since its founding, and has evolved its coating technology to develop systemically acting tape formulations and film formulation technology. It also states that its film formulations (ODF and ADF) were the world's first to be commercialized as pharmaceuticals.

Products and positioning

Technology pharma (formulation-technology-driven pharmaceutical company) specializing in film formulations and patches.

  • Film formulations (ODF, ADF)

    Orally Rapid Disintegration Film Formula (ODF) and Adhesive and Disintegration Film Applicable to Oral Mucosa (ADF); stated to be the world's first commercialized as pharmaceuticals.

  • Anti-inflammatory analgesic poultices

    External patch formulation for the orthopedic field.

  • Topical analgesic/anti-inflammatory tapes

    Topical tape formulation for the orthopedic field.

  • Systemically acting transdermal tapes

    Transdermal tape formulation developed from coating technology.

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/kyukyu-pharmaceutical-co-ltd-japan · Editorial policy · How profiles are compiled